Pabel (Biotechnology) Overview
- Year Founded
-
2025
- Status
-
Private
- Employees
-
2
- Latest Deal Type
-
Early Stage VC
- Investors
-
1
Pabel (Biotechnology) General Information
Description
Operator of an artificial intelligence research laboratory intended to advance precision neurology and psychiatry. The company's platform develops foundation models trained on large-scale clinical electroencephalogram data to learn reusable representations of brain function, enabling researchers to identify biomarkers of therapeutic response and accelerate central nervous system drug development through the analysis of complex neural activity.
Contact Information
Website
www.pabel.aiCorporate Office
- Keizersgracht 520 H
- 1017 EK Amsterdam
- Netherlands
Corporate Office
- Keizersgracht 520 H
- 1017 EK Amsterdam
- Netherlands
Pabel (Biotechnology) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC | 01-Jan-2026 | Completed | Generating Revenue |
Pabel (Biotechnology) Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Pabel (Biotechnology) Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Pabel (Biotechnology) Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| ASIF Ventures | Venture Capital | Minority |
Pabel (Biotechnology) FAQs
-
When was Pabel (Biotechnology) founded?
Pabel (Biotechnology) was founded in 2025.
-
Where is Pabel (Biotechnology) headquartered?
Pabel (Biotechnology) is headquartered in Amsterdam, Netherlands.
-
What is the size of Pabel (Biotechnology)?
Pabel (Biotechnology) has 2 total employees.
-
What industry is Pabel (Biotechnology) in?
Pabel (Biotechnology)’s primary industry is Biotechnology.
-
Is Pabel (Biotechnology) a private or public company?
Pabel (Biotechnology) is a Private company.
-
What is Pabel (Biotechnology)’s current revenue?
The current revenue for Pabel (Biotechnology) is .
-
Who are Pabel (Biotechnology)’s investors?
ASIF Ventures has invested in Pabel (Biotechnology).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
